TP53 and cancer: To investigate whether the biological effect of PANDAR was related to its binding ability with p53 protein, we performed RNA immunoprecipitation (RIP) experiments with p53 wild-type cancer cells (AGS, SNU-520 and SNU-1) (Fig. 5a).